drugset / Trial / NCT00456417
Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects
Phase 1
Completed
30 enrolled
Institute for Neurodegenerative Disorders
Molecular NeuroImaging · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The underlying goal of this study is to assess 123-I MNI-187 SPECT imaging as a tool to detect ß-amyloid deposition in the brain of AD research participants and age- and gender-matched healthy subjects.
Timeline
- Start
- 2007-04
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 123-I MNI-187 | Diagnostic / imaging agent | — | Other |